As per Intent Market Research, the clinical decision support systems market was valued at USD 1.9 billion in 2023-e and will surpass USD 3.1 billion by 2030; growing at a CAGR of 8.1% during 2024 - 2030. The market is thriving due to the growing adoption of CDSS-enabled Electronic Health Records (EHRs).

During the COVID-19 pandemic, countries heavily relied on online services to sustain their health systems. Virtual consultations between healthcare professionals and patients became prevalent, primarily due to strict lockdown measures imposed by various governments in the early stages of the pandemic. The global impact of the COVID-19 outbreak underscored the crucial role played by clinical decision support systems in aiding patient resources and services.

The article published in the “Journal Plos One” in March 2021, they have emphasized the paramount importance of developing real-time clinical diagnosis decision support tools for COVID-19. These tools were instrumental in patient triage and resource allocation for individuals at risk. The widespread adoption of online services by several countries contributed to the market's growth.

Moreover, market players responded to the demand by introducing clinical decision support systems tailored for managing COVID-19 data and insights. For instance, in May 2022, Epocrates, a subsidiary of Athenahealth, announced its latest enhancements to the content within its decision support tool. These updates aim to equip clinicians with up-to-date information and expert guidance, empowering them with swift access to critical insights for evaluating and treating medical conditions. This ensures that clinicians can make well-informed decisions at the point of care, underscoring the importance of having timely and reliable information readily available.

Increasing Implementation of Government Regulations & Initiatives to Drive the Clinical Decision Support Systems Market

The CDSS market is expected to experience a significant boost due to the growing implementation of government regulations and initiatives. In May 2020, the Centers for Medicare & Medicaid Services made a notable decision to exercise enforcement discretion, refraining from taking action against specific payer-to-payer data exchange provisions, as indicated in a Federal Register Notice. The Biden administration emphasized the administration's commitment to enhance health data exchange and encouraging investments in interoperability through insights shared in a blog.  

Furthermore, European Union Health Ministers collectively endorsed a statement in Europe with the aim of establishing an eHealth common area, facilitating the unrestricted movement of Electronic Health Records (EHR) across the continent. This statement also highlights the integration of eHealth into the Europe 2020 strategy. In support of advancing digital health, the UK government has pledged a significant investment of USD 347 million to promote research & development, fostering the creation of new pharmaceuticals, devices, and diagnostic tools.

These regulatory initiatives are anticipated to catalyze an increased adoption of Electronic Health Records (EHR). Consequently, this surge in EHR adoption is poised to influence and drive the widespread adoption of CDSS across major markets worldwide.

Big Data and mHealth Tools offers Opportunities for Market Growth

The development of CDSS is significantly influenced by the evolution of big data and mobile health (mHealth) tools. These technological advancements play a crucial role in enhancing the capabilities and effectiveness of CDSS. Big Data provides the infrastructure to handle and analyze vast amounts of healthcare data. CDSS can leverage advanced analytics to process diverse datasets, including EHRs, genomics, and real-time patient monitoring data. Mobile health tools offer clinicians and healthcare providers the ability to access CDSS from anywhere, facilitating point-of-care decision support thereby ensuring timely and informed decision-making.

Conventional CDSS Revolutionizes the Clinical Decision Support Systems Market

The conventional CDSS segment holds the largest share of the CDSS market. This dominance is primarily attributed to the widespread adoption of conventional decision support systems by clinicians at the point of care. These systems analyze patient data, medical history, and current information to provide real-time insights and evidence-based recommendations.

Conventional CDSS contributes to enhanced diagnostic accuracy, treatment planning, and overall patient care. Their integration fosters efficiency, reduces errors, and promotes adherence to best practices, thereby improving healthcare outcomes. In the clinical decision support systems market, these conventional systems continue to serve as foundational tools, ensuring the delivery of high-quality, evidence-driven healthcare.

The Surge of Integrated CDSS in Response to Cost Pressures and the Aging Population is aiding the Market Growth

The growth of the integrated CDSS segment is propelled by factors such as the mounting pressure to reduce healthcare costs, the increasing aging population, and a rising incidence of chronic disorders. Healthcare providers widely employ integrated CDSS to elevate the quality of care and health outcomes while simultaneously reducing medication errors. These systems integrate patient data, medical knowledge, and advanced algorithms to provide real-time, personalized recommendations to healthcare professionals.

Source: Intent Market Research Analysis

North America Holds a Significant Market Share due to the High Government Spending in Healthcare Infrastructure

In 2023, North America is anticipated to lead in market share. This leadership position can be attributed to several factors, including the presence of key players in the region, significant investments in Healthcare Information Technology solutions, and a noticeable increase in medication errors in the US and Canada.

The increasing funding from the US government for supporting healthcare is an attributing factor for the market growth. For instance, the Congressional Budget Office, 2021, published that in the past few decades, federal funding for the National Institute of Health (NIH) has totaled over USD 700 billion.

Additionally, the increasingly advanced product launches in this region by various market players are also expected to contribute to the market growth. In August 2021, First Databank introduced FDB CDS Analytics; an innovative solution which empowers healthcare providers to effortlessly recognize, track, and tailor Clinical Decision Support (CDS) within their EHR. The overarching goal is to elevate clinician user experiences and amplify the impact of CDS across all care areas, ultimately contributing to the improvement of patient outcomes.

Moreover, in June 2021, Pathway, a clinical decision support platform raised USD1.3 million to scale its CDS platform. With this financing, the company aimed to enhance clinical decision support systems which eventually increase healthcare efficiency. These factors such as increasing investments, CDSS launches, and high funding for healthcare, fuel the growth of the CDSS market over the forecast period in North America.

The Key Players are Highly Competitive to Capture the Market Share

The market is characterized by intense competition due to the presence of numerous international and domestic players. The CDSS market, in particular, is dominated by key players such as 3M Health Information Systems, Allscripts, Cerner Corporation, Change Healthcare, Elsevier BV, Epic Systems, GE Healthcare, IBM Watson Health, McKesson Corporation, Meditech, NextGen Healthcare, Oracle, Philips Healthcare, Siemens Healthineers, and Wolters Kluwer Health, amongst others. Prominent players in the CDSS market are actively engaged in advancing their positions through the development and introduction of innovative CDSS devices.

Clinical Decision Support Systems Market Coverage

The report provides key insights into the clinical decision support systems market, and it focuses on technological developments, trends, and initiatives taken by the government in this sector. The report delves into market drivers, restraints, and opportunities, and analyses key players and the competitive landscape within the market. The report offers the market size and forecasts for the clinical decision support systems market in value (USD billion) for all the above segments.

Report Scope